Advertisement
Screener

MYRIAD GENETICS, INC. (MYGN) Gain (Loss) on Disposition of Assets

2.1 / 5 stars · 50/120 Roast Me

MYRIAD GENETICS, INC. Gain (Loss) on Disposition of Assets

MYRIAD GENETICS, INC. (MYGN) reported Gain (Loss) on Disposition of Assets of $162.00 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.

Discontinued › Income Statement › Other Income

us-gaap:GainLossOnDispositionOfAssets1 · last filed 2021-11-04

  • MYRIAD GENETICS, INC. gain (loss) on disposition of assets for the quarter ending 2021-09-30 was $129.60M, a 12860.00% increase year-over-year.
  • MYRIAD GENETICS, INC. gain (loss) on disposition of assets for the quarter ending 2020-09-30 was $1.00M.
Period endGain (Loss) on Disposition of Assets 3 monthGain (Loss) on Disposition of Assets 6 monthGain (Loss) on Disposition of Assets 9 month
2021-09-30$129.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$162.00M
10-Q · filed 2021-11-04
2021-06-30$32.40M
10-Q · filed 2021-08-04
2020-09-30$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$1.00M
10-Q · filed 2021-11-04
2020-06-30$0.00
10-Q · filed 2021-08-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92